ClinTec appoints Rick Farris as EVP of North American Operations
ClinTec International has announced the appointment of Rick Farris as executive vice president of Operations for North America, as the organization continues to deliver on plans for growth in its clinical research capabilities in the U.S.
With almost 30 years of experience in the life sciences industry, Rick joins ClinTec International from Novella Clinical, a Quintiles-owned company, where he held the position of vice president in Project Management for the Biopharma and Rare Disease Business Unit. Rick provided client relationship management and project oversight for clinical trials in rare diseases, oncology, hematology, infectious disease, dermatitis, pain management and gastroenterology.
Previously, he served as chief operating officer at Health Decisions, a U.S.-based CRO specializing in female reproductive health, rare disease, diagnostic devices and oncology. Prior to his focus on clinical research, he worked within the healthcare technology industry providing solutions for patient information management, electronic health records, clinical management and financial management within the clinical environment.
Farris commented, “As ClinTec’s Executive Vice-President of Operations for North America, I am thrilled to be joining the organization at a time of significant global growth, with the USA being a key market of strategic importance to our company. I look forward to working with ClinTec’s executive leadership as well as the USA leadership team to expand further our presence in North America by providing highly responsive and top quality research services, seamlessly integrated with the outputs from our teams across the globe. With so many trials struggling with enrollment, particularly in rare disease and oncology, ClinTec’s global footprint and permanent staff in 50 countries offers a unique opportunity for North American based companies needing to find patients wherever they are.”
The CEO and founder of ClinTec International Dr. Rabinder Buttar remarked, “As ClinTec approaches its 20th year of significant organic growth, we are excited about our expansion plans in North America where we have a growing number of new clients. Rick will provide executive leadership to our teams and keep in close contact with our clients to ensure that as we continue to maintain our focus on high quality project delivery, remain highly responsive to client needs and provide a high level of customer service”.
ClinTec International, a privately owned CRO, was formed nearly 20 years ago by its CEO and Chairman Dr Rabinder Buttar. With capabilities in over 80 countries, ClinTec delivers innovative, customized clinical research solutions and talented personnel resourcing to the clinical development sector in a fast, flexible and focused way.